Company agreed to provide an unrestricted educational grant to the Vagus Nerve Society and provided educational and directed research grants.
| Officer | Age | 2025 pay | Source |
|---|---|---|---|
|
Joshua S. Lev
Also a director
See Remarks
Title from the Form 4 dated Sep 8, 2026
|
41 | $707,480 | |
|
Michael P. Fox
Also a director
See Remarks
Title from the Form 4/A dated Sep 11, 2026
|
59 | Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Jul 20, 2026 · updated by the 8-K of Sep 9, 2026
| Director | Age | On board | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|
|
Thomas J. Errico, M.D.
Board chair
|
74 |
2005
21 years
|
None stated | $214,995 | |
|
James C. Theofilos
|
31 | Not stated | None stated | Not stated | |
|
Elena Bonfiglioli
|
54 | Not stated | None stated | $162,496 | |
|
John P. Gandolfo
|
65 |
2020
6 years
|
Oragenics, Inc | $174,998 | |
|
Julie A. Goldstein
|
67 |
2022
4 years
|
None stated | $162,498 | |
|
Patricia Wilber
|
64 |
2022
4 years
|
Zapp Electric Vehicles Group Limited | $164,998 | |
|
Joshua S. Lev
Joined Sep 8, 2026
|
- | - | - | - | |
|
Michael Fox
Joined Sep 8, 2026
|
- | - | - | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
Company agreed to provide an unrestricted educational grant to the Vagus Nerve Society and provided educational and directed research grants.
Consulting agreement for consulting and advisory services to the CEO, with hourly or per diem fees and a stock option for 50,000 shares at $6.43 per share.
Consulting agreement for financial and accounting consulting services on an hourly basis.
License agreement giving the Chinese company access to develop products based on certain nVNS patents in certain territories, with a 10% royalty to the Company; no royalties received in 2025.
Separation agreement under which he retired, provides advisory and transition services for one year after April 1, 2026, and has a right to invest pari passu in certain equity offerings through August 31, 2028.
Loading...